Shorter interval between cycles of cyclophosphamide, doxorubicin, cisplatin using recombinant human granulocyte colony-stimulating factor for urothelial cancer--phase I/II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples